Genetic and Environmental Risk Factors for Hemorrhagic Stroke
Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · May 20, 2008
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the risk factors that can lead to hemorrhagic stroke, which is a type of stroke caused by bleeding in the brain. Researchers want to explore both genetic (things we inherit from our parents) and environmental (influences from our surroundings) factors that might contribute to this condition. The study is currently active, but they are not looking for new participants at this time.
To be eligible for the study, participants must be at least 18 years old and have lived in the area for at least six months. They need to have had a specific type of bleeding in the brain without any other causes, like trauma or tumors. Participants will be asked to provide consent for an interview, some basic health measurements, and a blood sample to help researchers gather important information. This study aims to improve our understanding of hemorrhagic stroke, which could eventually help in preventing and treating this serious condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Resident (6 months or longer) within the recruitment center
- • Fulfillment of the criteria for spontaneous ICH
- • No evidence of trauma, brain tumor/metastases or infectious processes as a cause of the hemorrhage
- • Ability of the patient or legal representative to provide consent for an interview, blood pressure determinations and DNA sampling
- Exclusion Criteria:
- • N/A
About State University Of New York At Buffalo
The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Baltimore, Maryland, United States
Cincinnati, Ohio, United States
Durham, North Carolina, United States
Louisville, Kentucky, United States
New York, New York, United States
Chicago, Illinois, United States
Patients applied
Trial Officials
Daniel Woo, MD
Principal Investigator
University of Cincinnati
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials